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Objective: To analyse whether bone mineral density
(BMD) assessment is required in postmenopausal women
presenting with low trauma vertebral fracture.
Methods: Women with vertebral fracture diagnosed over
a 10 year period were recruited from our database. The
following were excluded: (a) patients with high energy
trauma; (b) patients with malignancies; (c) patients with a
metabolic bone disease other than osteoporosis. All
postmenopausal women were included in whom BMD had
been evaluated at both the lumbar spine and femoral neck
by dual energy x ray absorptiometry during the six months
after the diagnosis. Patients with a potential cause of
osteoporosis other than age and menopause were not con-
sidered. A total of 215 patients were identified.
Results: The mean (SD) age of the patients was 65.9 (6.9)
years. BMD at the lumbar spine was 0.725 (0.128) g/cm2
and the T score was −2.94 (1.22); BMD at the femoral
neck was 0.598 (0.095) g/cm2 and the T score was
−2.22 (0.89). The BMD of the patients was significantly
lower than that of the general population at both the lum-
bar spine and femoral neck. When the lowest value of the
two analysed zones was considered, six patients (3%)
showed a normal BMD, 51 (23.5%) osteopenia, and 158
(73.5%) osteoporosis. The prevalence of osteoporosis at
the femoral neck increased with age; it was 25% in
patients under 60, 35% in patients aged 60–70, and 60%
in patients over 70.
Conclusion: These results indicate that bone densitometry
is not required in postmenopausal women with clinically
diagnosed vertebral fractures if it is performed only to con-
firm the existence of a low BMD.
Astrong relation exists between bone mineral density(BMD) measured by dual energy x ray absorptiometry(DXA) and the risk of fracture.1 Fracture risk increases
with decreasing BMD, so that there is no exact cut off point to
characterise absolutely a person who will fracture from one
who will not.2
The consensus definition3 of osteoporosis captures the
notion that low BMD is an important component of the risk of
fracture. Furthermore, the operative definition4 is based on
BMD status; in 1994, an expert panel of the World Health
Organisation (WHO) recommended thresholds of BMD in
women to define osteopenia and osteoporosis.
It is clear that the relation between fracture risk and bone
density is best described as a gradient rather than a threshold.
However,WHO thresholds are useful in clinical practice to give
information on prognosis. Moreover, although risk factors
independent of bone mass should also be considered,2 BMD
status is the main factor in the decision on intervention, and
WHO thresholds are used as cut off points.5 6
Unfortunately, the generalised use of DXA is limited
because it is expensive and time consuming, it is not portable,
and it is available only in specialised clinics. It is therefore only
feasible to use it to investigate patients at high risk of
osteoporosis. Thus, a previous fragility fracture is a classic
indication for bone densitometry,7 which is supported by the
more recent guidelines.8 However, it has also been suggested
that, when low trauma vertebral fracture is diagnosed,
patients can receive specific treatment for osteoporosis
without measurement of BMD.9
We studied a group of postmenopausal women with
clinically diagnosed vertebral fracture, seen in a rheumatology
department over 10 years, in order to evaluate the incidence of
osteopenia and osteoporosis according to WHO criteria. Our
aim was to analyse whether BMD assessment is required in
women with low trauma vertebral fracture.
PATIENTS AND METHODS
The study was performed at the rheumatology department of
the Ciutat Sanitària I Universitària de Bellvitge, a 1000 bed
teaching hospital in Barcelona, Spain. The department has a
14 bed unit for admissions and four outpatient clinics, one in
the hospital and the other three in affiliated primary care
health centres. In our area, patients with suspected osteo-
porotic fracture are usually referred to staff members of the
rheumatology department for specialist opinion. The depart-
ment has an established protocol for the evaluation of patients
with vertebral fractures.
Women with vertebral fracture diagnosed between January
1990 and December 1999 were recruited from our database.
Only patients who consulted for back pain were included;
asymptomatic patients in whom diagnosis was established on
the basis of radiological studies performed for other clinical
problems were not considered. A 20% reduction in the height
of the anterior,mid, or posterior vertebra was taken to indicate
the presence of a fracture; radiographs were not examined by
the same rheumatologist and were not digitised. We excluded
patients with high energy trauma, malignancies, or metabolic
bone disease other than osteoporosis. A total of 534 patients
were identified. Mean age was 67.8 (8.6) years (range 30–91).
The fracture was single in 272 (51%) cases and multiple in 262
(49%).
Patients (n = 103) with a potential cause of bone loss other
than age and menopause were not considered. From the
remainder (n = 431), we selected patients in whom a BMD
assessment had been performed at both the lumbar spine and
femoral neck, in our bone densitometry unit, during the six
months after the diagnosis of vertebral fracture; 215 patients
fulfilled the requirements and were included in the study.
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Patients included (n = 215) were younger (65.9 (6.9) years
v 69.4 (9.2) years; p<0.01) than those not included (n = 216);
the proportion of patients with multiple fractures was similar
(41% v 50%).
BMD (g/cm2) was measured at the lumbar spine (L2–4) and
femoral neck by DXA using a Hologic QDR1000 unit (Hologic
Inc, Waltham, Massachusetts, USA). Calibration with a
lumbar spine phantom was performed daily and with a femo-
ral phantom weakly.
T score and Z score were established by comparison with
data from the study of BMD at the lumbar spine and femoral
neck in a Spanish population, performed by the Multicentre
Research Project on Osteoporosis (MRPO).10 The aim of this
study was to generate standard curves for BMD at both sites.
The total sample size was 2442 subjects of both sexes aged
20–80 years, stratified according to survival rates, demo-
graphic distribution by local regions, and sex ratio in the
Spanish population. BMD measurements were performed
with a Hologic QDR device. The MRPO members considered
that the results obtained were representative of BMD values in
the Spanish population.As recommended byMRPOmembers,
the age range from which normal values were derived for cal-
culation of T scores was 20–44 years for the lumbar spine and
20–29 years for the femoral neck. We used the WHO
thresholds4 to classify our patients into three diagnostic
categories as follows: (a) normal, a BMD T score greater than
−1 SD; (b) osteopenia, a T score between −1 and −2.5 SD; (c)
osteoporosis, a T score below −2.5 SD.
Results are expressed as mean (SD). Confidence interval
(CI) was used to assess the difference between the mean Z
score at each site and that of the general population. For com-
parison between categorical variables, a χ2 test was applied.
Correlation between continuous variables was calculated by
the Pearson test. Differences between groups were calculated
by analysis of variance. p<0.05 was considered significant.
RESULTS
The mean age of the patients was 65.9 (6.9) years (range
45–83). A single fracture was found in 126 (59%) patients, and
multiple fractures in the remainder. Patients with a single
fracture were younger than those with multiple fractures.
(65.1 (7.1) years v 67.1 (6.4) years; p<0.05).
The BMD at the lumbar spine was 0.725 (0.128) g/cm2 and
the T score was −2.94 (1.22). The BMD at the femoral neck was
0.598 (0.095) g/cm2 and the T score was −2.22 (0.89).
The BMD of the patients was significantly lower than that
of the general population at both sites; the Z score at the lum-
bar spine was −0.91 (1.00) (95% CI −1.04 to −0.78) and that at
the femoral neck was −0.84 (0.89) (95% CI −0.96 to −0.72).
BMD was related to age of the patients at both the lumbar
spine (r=−0.15; p<0.05) and femoral neck (r =−0.35;
p<0.01). The correlation coefficient between BMD at the lum-
bar spine and femoral neck was 0.48 (p<0.001).
When the lowest value of the two analysed zones was con-
sidered, six patients (3%) had a normal BMD, 51 (23.5%) had
osteopenia, and 158 (73.5%) had osteoporosis; table 1 shows
the percentage of patients assigned to each WHO category
when the patients were classified according to several age
ranges.
Sixty eight (31.5%) patients had combined osteoporosis at
the lumbar spine and femoral neck. Almost half (49%) of the
patients with osteoporosis at the lumbar spine also had osteo-
porosis at the femoral neck.
Table 2 shows the percentage of patients assigned to each
WHO category from the BMD status at the lumbar spine and
femoral neck. Table 3 shows the same data when the patients
were classified according to several age ranges. Table 4 shows
data obtained when different T score thresholds were applied.
When patients were classified according to the number of
vertebral fractures (single v multiple), no differences were
found in the BMD at the lumbar spine (0.731 (0.126) g/cm2 v
0.716 (0.131) g/cm2) or femoral neck (0.607 (0.098) g/cm2 v
0.584 (0.088) g/cm2), nor in the T score at the lumbar spine
(−2.87 (1.19) v −3.03 (1.26)) or femoral neck (−2.13 (0.092) v
−2.34 (0.083)). Finally, we found no differences in WHO diag-
nostic categories (tables 5 and 6).
Table 1 Number (%) of patients (n=210) assigned








Normal 2 (6) 3 (3) 0
Osteopenia 5 (16) 36 (31) 8 (13)
Osteoporosis 25 (78) 76 (66) 55 (87)
Classification by age (years) distribution. Patients under 50 (n=2) and
over 80 (n=3) were not considered.
Table 2 Number (%) of patients (n=215) assigned
to each WHO category from the bone mineral density
status at the lumbar spine and femoral neck
Lumbar spine Femoral neck
Normal 12 (5) 18 (8)
Osteopenia 64 (30) 110 (51)
Osteoporosis 139 (65) 87 (41)
Table 3 Number (%) of patients (n=210) assigned
to each WHO category from the bone mineral density








Normal 2 (6) 7 (6) 2 (3)
Osteopenia 6 (19) 41 (36) 15 (24)
Osteoporosis 24 (75) 67 (58) 46 (73)
Femoral neck
Normal 4 (13) 11 (10) 1 (2)
Osteopenia 20 (62) 64 (55) 24 (38)
Osteoporosis 8 (25) 40 (35) 38 (60)
Classification by age (years) distribution. Patients under 50 (n=2) and
over 80 (n=3) were not considered.
Table 4 Number (%) of patients (n=210) assigned









T<−1 30 (94) 108 (94) 61 (97)
T<−1.5 27 (84) 101 (88) 60 (95)
T<−2 27 (84) 90 (78) 56 (88)
T<−2.5 24 (75) 67 (58) 46 (73)
T<−3 19 (59) 51 (44) 39 (62)
Femoral neck
T<−1 28 (87) 104 (90) 62 (98)
T<−1.5 21 (67) 89 (77) 60 (95)
T<−2 11 (34) 68 (59) 54 (85)
T<−2.5 8 (25) 40 (35) 38 (60)
T<−3 2 (6) 20 (17) 18 (29)
Classification by age (years) distribution. Patients under 50 (n=2) and
over 80 (n=3) were not considered.
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DISCUSSION
We have studied the BMD status in a large series of Spanish
postmenopausal women suffering from vertebral fracture.
Patients withmalignancies,metabolic bone disease other than
osteoporosis, or high energy trauma were excluded.Moreover,
patients with a potential cause for bone loss other than age
and menopause were not considered in order to homogenise
the series.
The study was performed in a clinical setting and should be
interpreted in the light of several considerations. Although we
asked patients about the existence of a high energy trauma, it
is possible that a unmemorable episode may have been
overlooked; nonetheless, we are confident that the effect of
this possibility on the overall series is extremely low.
We included only symptomatic patients. However, there was
no attempt to differentiate between recent and chronic back
pain.
Radiographs were not digitised when we measured the
reduction in vertebral height; moreover, they were evaluated
by several clinicians and we have not analysed the degree of
agreement between the examiners.
Finally, we have not systematically indicated a BMD assess-
ment in our patients. Only half of the patients fulfilled the
requirements for the study. Patients included in the study
were younger than those not included, probably reflecting a
trend to avoid the performance of bone densitometry in older
women.
Despite these criticisms, the results may help to clarify the
value of bone densitometry assessment in patients with verte-
bral fracture.
As expected, the BMD of the patients was significantly
lower than that of the general population. Correlation between
age and BMD was more pronounced at the femoral neck than
the lumbar spine, probably reflecting the impact of the
presence of osteophytes or fractures. Correlation between
spine and femoral BMD was only moderate. Measurements of
the skeleton at one site correlate with measurements made at
other skeletal sites, correlation coefficients ranging from 0.5 to
0.8; the correlations are closer in the young healthy population
than in patients with significant bone loss.11 Thus, the correla-
tion obtained between spine and femoral BMD in this study
was clearly less close than that observed in a recent study12
performed in postmenopausal women without vertebral frac-
tures and with a lower mean age.
The percentage of patients with normal BMD was very low.
Three quarters of patients showed signs of osteoporosis at the
lumbar spine and/or femoral neck; furthermore, almost 90%
of patients aged 70–79 had osteoporosis at the lumbar spine
and femoral neck combined.
On the other hand, the incidence of osteoporosis at the
femoral neck increased with age in the different groups, prob-
ably in accord with the pattern of bone loss in postmenopau-
sal women; in patients under 60 it was 25% and in patients
over 70 it was 60%.
The results obtained support the proposal that bone densi-
tometry in postmenopausal women with a fragility vertebral
fracture is not required if it is performed only to confirm the
existence of a low BMD.
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Table 5 Number (%) of patients (n=215) assigned
to each WHO category using the lowest value of the
two analysed regions
Single (n=126) Multiple (n=89)
Normal 5 (4) 1 (1)
Osteopenia 31 (25) 20 (23)
Osteoporosis 90 (71) 68 (76)
Patients are classified on the basis of the number of vertebral
fractures.
Table 6 Number (%) of patients (n=215) assigned
to each WHO category from the bone mineral density
status at the lumbar spine and femoral neck
Single (n=126) Multiple (n=89)
Lumbar spine
Normal 8 (6) 4 (5)
Osteopenia 38 (30) 26 (29)
Osteoporosis 80 (64) 59 (66)
Femoral neck
Normal 12 (10) 6 (7)
Osteopenia 66 (52) 44 (49)
Osteoporosis 48 (38) 39 (44)
Patients are classified on the basis of the number of vertebral
fractures.
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